PETV (PetVivo Holdings) Long-Term Debt: $0.00 Mil (As of Mar. 2026)


PETV PetVivo Holdings Inc PETV
31 GF Score
Price $0.80
GF Value $0.51
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is PetVivo Holdings Long-Term Debt?

PetVivo Holdings PETV -4.65% 31 Long-Term Debt is $0.00 Mil as of Mar. 2026. GuruFocus rates PETV with a GF Score™ of 31/100 and a GF Value™ of $0.51 (Significantly Overvalued). The stock has 6 warning signs investors should review.

PetVivo Holdings's Long-Term Debt for the quarter that ended in Mar. 2026 was $0.00 Mil.

PetVivo Holdings's annual Long-Term Debt declined from Mar. 2024 ($0.01 Mil) to Mar. 2025 ($0.01 Mil) and declined from Mar. 2025 ($0.01 Mil) to Mar. 2026 ($0.00 Mil).

PetVivo Holdings  (OTCPK:PETV) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

PetVivo Holdings Long-Term Debt Related Terms

PetVivo Holdings Long-Term Debt Historical Data

* Premium members only.

The historical data trend for PetVivo Holdings's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PetVivo Holdings Long-Term Debt Chart

PetVivo Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.24 0.01 0.01 0.00

PetVivo Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.00 0.00 0.00 0.00
PETV
31GF Score
PetVivo Holdings Inc PETV
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.00 Mil mean?
PetVivo Holdings (PETV) has a Long-Term Debt of $0.00 Mil as of Mar. 2026.
Is PetVivo Holdings' Long-Term Debt too high?
PetVivo Holdings' current Long-Term Debt is $0.00 Mil. Overall, PetVivo Holdings has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PetVivo Holdings' Long-Term Debt compare to ARAY and RDGL?
PetVivo Holdings' Long-Term Debt of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. PetVivo Holdings's current Long-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetVivo Holdings stock overvalued right now?
Based on GuruFocus' analysis, PetVivo Holdings (PETV) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.51, compared to a current price of $0.80 — trading 56.9% above its estimated fair value. The current Long-Term Debt is $0.00 Mil. PetVivo Holdings' overall GF Score™ is 31/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For PetVivo Holdings (PETV), the current Long-Term Debt is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PetVivo Holdings (PETV) Overvalued in 2026?

Based on GuruFocus' analysis, PetVivo Holdings stock appears to be overvalued. The current stock price of $0.80 is trading 56.9% above its estimated GF Value™ of $0.51. GuruFocus considers PetVivo Holdings to be Significantly Overvalued.

Key valuation signals for PETV:

  • Long-Term Debt: $0.00 Mil
  • GF Value™: $0.51 vs. price of $0.80 (56.9% above fair value)
  • GF Score™: 31/100 with 6 warning signs

No single metric tells the full story. See the PETV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PetVivo Holdings Business Description

Address 5151 Edina Industrial Boulevard, Suite 575, Edina, MN, USA, 55439
PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.
31GF Score

Get the complete analysis for PETV

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.80
Price
$0.51
GF Value